Back to
Qube Research & Technologies Ltd
TPST
Showing 1 of 5 quarters
Position history for
Qube Research & Technologies Ltd's holdings in Tempest Therapeutics, Inc.
No. Qube Research & Technologies exited its TPST (Tempest Therapeutics) position in Q3 2024. Its Q2 2024 13F listed 27 shares worth $59. Qube Research & Technologies first reported TPST in Q3 2023 and held it in 4 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History